References and Notes
1. Mole RH. Ionising radiation as a carcinogen: practical questions and academic pursuits. The Silvanus Thompson Memorial Lecture delivered at The British Institute of Radiology on 18 April 1974. Br J Radiol 48:157-169 (1975).
2. ICRP. Recommendations of the International Commission on Radiological Protection (Publication 1). New York:Pergamon Press, 1959.
3. De Brouwer C, Lagasse R. The European directive 96/29/Euratom through the history of radiation protection. Rev Med Brux 22:33-41 (2001).
4. ICRP. Recommendations of the International Comission on Radiological Protection (Publication 26). NewYork:Pergamon Press, 1991.
5. ICRP. Recommendations of the International Comission on Radiological Protection (Publication 60). NewYork:Pergamon Press, 1990.
6. Harris CC. P53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment. Environ Health Perspect 104(suppl 3):435-439 (1996).
7. Little JB. Radiation-induced genomic instability. Int J Radiat Biol 74:663-671 (1998).
8. Bryant PE. DNA damage, repair and chromosomal damage. Int J Radiat Biol 71:675-680 (1997).
9. Kennedy AR, Little JB. Evidence that a second event in X-ray-induced oncogenic transformation in vitro occurs during cellular proliferation. Radiat Res 99:228-248 (1984).
10. Mothersill C, Crean M, Lyons M, McSweeney J, Mooney R, O'Reilly J, Seymour CB. Expression of delayed toxicity and lethal mutations in the progeny of human cells surviving exposure to radiation and other environmental mutagens. Int J Radiat Biol 74:673-680 (1998).
11. Mothersill C, Seymour C. Lethal mutations and genomic instability. Int J Radiat Biol 71:751-758 (1997).
12. Joiner MC, Lambin P, Malaise EP, Robson T, Arrand JE, Skov KA, Marples B. Hypersensitivity to very low single radiation doses: its relationship to the adaptive response and induced radioresistance. Mut Res 358:171-183 (1996).
13. Marples B, Lambin P, Skov KA, Joiner MC. Low dose hyper-radiosensitivity and increased radioresistance in mammalian cells. Int J Radiat Biol 71:721-735 (1997).
14. Wiencke JK, Afzal V, Olivieri G, Wolff S. Evidence that the [H-3]thymidine-induced adaptative response of human lymphocytes to subsequent doses of X-rays involves the induction of a chromosomal repair mechanism. Mutagenesis 1:375-380 (1986).
15. Wolff S. The adaptive response in radiobiology: evolving insights and implications. Environ Health Perspect 106 (suppl 1):277-283 (1998).
16. Wolff S, Afzal V, Wiencke JK, Olivieri G, Michaeli A. Human lymphocytes exposed to low doses of ionizing radiation become refractory to high doses of radiation as well as to chemical mutagens that induce double-strand breaks in DNA. Int J Radiat Biol 53:39-48 (1988).
17. Ullrich RL, Ponnaiya B. Radiation-induced instability and its relation to radiation carcinogenesis. Int J Radiat Biol 74:747-754 (1998).
18. Loeb LA. Transient expression of a mutator phenotype in cancer cells. Science 277:1449-1451 (1997).
19. Prise KM, Belyakov OV, Folkard M, Michael BD. Studies of bystander effects in human fibroblasts using a charged particle microbeam. Int J Radiat Biol 74: 793-798 (1998).
20. Miller AB, Howe GR, Sherman GJ, Lindsay JP, Yaffe MJ, Dinner PJ, Risch HA, Preston DL. Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. N Engl J Med 321:1285-1289 (1989).
21. Kathren RL. Pathway to a paradigm: the linear nonthreshold dose-response model in historical context: the American Academy of Health Physics 1995 Radiology Centennial Hartman Oration. Health Phys 70:621-635 (1996).
22. Mossman KL. The linear no-threhold debate: where do we go from here? Med Phys 25:279-284 (1998).
23. Nussbaum RH. The linear no-threshold dose effect relation: is it relevant to radiation protection regulation? Med Phys 25:291-300 (1998).
24. Sinclair WK. The linear no-threshold response: why not linearity? Med Phys 25:285-290 (1998).
25. Committee on the Biological Effects of Ionizing Radiation (BEIR V). Health Effects of Exposure to Low Levels of Ionizing Radiation. Washington DC:National Academy Press, 1990.
26. Samet JM, Eradze GR. Radon and lung cancer risk: taking stock at the millenium. Environ Health Perspect 108 (suppl 4):635-641 (2000).
27. Cohen BL. Test of the linear-no threshold theory of radiation carcinogenesis for inhaled radon decay products. Health Phys 68:157-174 (1995).
28. Lubin JH, Boice JD Jr. Lung cancer risk from residential radon: meta-analysis of eight epidemiologic studies. J Natl Cancer Inst 89:49-57 (1997).
29. Greenland S, Robins J. Ecologic studies--biases, misconceptions, and counterexamples. Am J Epidemiol 139:747-760 (1994).
30. Lubin HJ. Response to Cohen's comments on the Lubin rejoinder. Health Phys 77:330-332 (1999).
31. Field RW, Smith BJ, Lynch CF. Cohen's paradox. Health Phys 77:328-329 (1999).
32. Lubin JH, Boice JD Jr, Edling C, Hornung RW, Howe GR, Kunz E, Kusiak RA, Morrison HI, Radford EP, Samet JM, et al. Lung cancer in radon-exposed miners and estimation of risk from indoor exposure. J Natl Cancer Inst 87:817-827 (1995).
33. Goldsmith JR. The residential radon-lung cancer association in U.S. counties: a commentary. Health Phys 76:553-557 (1999).
34. Darby S, Doll R. Reply to Explaining the lung cancer versus radon exposure data for USA counties. [Letter] J Radiol Prot 20:221-222 (2000).
35. Rothman KJ. Modern Epidemiology. 1st ed. Boston:Little, Brown and Co., 1986.
36. Rothman KJ. Methodologic frontiers in environmental epidemiology. Environ Health Perspect 101(suppl 4):19-21 (1993).
37. Stewart A, Webb J, Hewitt D. A survey of childhood malignancies. Br Med J i:1495-1508 (1958).
38. Stewart A. The role of epidemiology in the detection of harmful effects of radiation. Environ Health Perspect 108:93-96 (2000).
39. MacMahon B. Prenatal X-ray exposure and childhood cancer. J Natl Cancer Inst 28:1173-1191 (1962).
40. MacMahon B. Susceptibility to radiation-induced leukemia. N Engl J Med 287:144-145 (1972).
41. MacMahon B. Some recent issues in low-exposure radiation epidemiology. Environ Health Perspect 81:131-135 (1989).
42. Wakeford R. The risk of childhood cancer from intrauterine and preconceptional exposure to ionizing radiation. Environ Health Perspect 103:1018-1025 (1995).
43. Doll R, Wakeford R. Risk of childhood cancer from fetal irradiation. Br Med J 70:130-139 (1997).
44. Boice JD, Miller RW. Childhood and adult cancer after intrauterine exposure to ionizing radiation. Teratology 59:227-233 (1999).
45. Wing S, Shy CM, Wood JL, Wolf S, Cragle DL, Frome EL. Mortality among workers at Oak Ridge National Laboratory. JAMA 265:1397-1402 (1991).
46. Rojas-Burke J. Oak Ridge cancer findings hotly disputed. J Nucl Med 32:11N-13N & 26N (1991).
47. Richardson DB, Wing S. Radiation and mortality of workers at Oak Ridge National Laboratory: positive associations for doses received at older ages. Environ Health Perspect 107:649-656 (1999).
48. Ashmore JP, Krewski D, Zielinski JM, Jiang H, Semenciw R, Band PR. First analysis of mortality and occupational radiation exposure based on the national dose registry of Canada. Am J Epidemiol 148:564-574 (1998).
49. Gardner MJ, Snee MP, Hall AJ, Powell CA, Downes S, Terell JD. Results of case-control study of leukemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria. Br Med J 300:423-429 (1990).
50. Parker L, Craft AW, Smith J, Diskinson H, Wakeford R, Binks K, McElvenny D, Scott L, Slovak A. Geographical distribution of preconceptional radiation doses to fathers employed at the Sellafield nuclear installation, West-Cumbria. Br Med J 307:966-971 (1993).
51. Evans HJ. Leukemia and radiation. Nature 345:16-17 (1990).
52. Sperling K, Pelz J, Wegner RD, Dörries A, Grűters A, Mikkelsen M. Significant increase in trisomy 21 in Berlin nine months after the Chernobyl reactor accident: temporal correlation or causal relation? Br Med J 309:158-161 (1994).
53. Scott D, Spreadborough A, Levine E, Roberts SA. Genetic predisposition in breast cancer [Letter]. Lancet 344:1444 (1994).
54. Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348:747-749 (1990).
55. Lavin MF, Bennett I, Ramsay J, Gardiner RA, Seymour GJ, Farell A, Walsh M. Indentification of a potentially radiosensitive subgroup among patients with breast cancer. J Natl Cancer Inst 86:1627-1634 (1994).
56. Land CE. Studies of cancer and radiation dose among atomic bomb survivors. JAMA 274:402-407 (1995).
57. Thompson DE, Mabuchi K, Ron E , Soda M, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Izumi S, et al. Cancer Incidence in Atomic bomb survivors. II: solid tumors, 1958-1987. Radiat Res 137:S17-S67 (1994).
58. Little MP, Muirhead CR. Evidence for curvilinearity in the cancer dose-response in the Japanese atomic bomb survivors. Int J Radiat Biol 70:83-94 (1996).
59. Stewart A. A-bomb data: detection of bias in the Life Span Study Cohort. Environ Health Perspect 105(suppl 6):1519-1521 (1997).
Last Updated: August 15, 2001